Nonclinical Safety Evaluation of Muraglitazar, a Novel PPARα/γ Agonist by Waites, Crystal R., Dominick, Mark A., Sanderson, Thomas P., Schilling, Beth E.

Get full text

Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPARα/γ Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action by Dominick, Mark A., White, Melvin R., Sanderson, Thomas P., van Vleet, Terry, Cohen, Samuel M., Arnold, Lora E., Cano, Marty, Tannehill-Gregg, Sarah, Moehlenkamp, Jeffrey D., Waites, Crystal R., Schilling, Beth E.

Get full text

Nonclinical safety evaluation of muraglitazar, a novel PPARalpha/gamma agonist by Waites, Crystal R, Dominick, Mark A, Sanderson, Thomas P, Schilling, Beth E

Get full text

Selective Inhibition of Phospholipases by Atiprimod, a Macrophage Targeting Antiarthritic Compound by Handler, Jeffrey A., Badger, Alison, Genell, Caroline A., Klinkner, Anne M., Kassis, Shouki, Waites, Crystal R., Bugelski, Peter J.

Get full text

Use of Clindamycin Disks To Detect Macrolide Resistance Mediated by ermB and mefE in Streptococcus pneumoniae Isolates from Adults and Children by WAITES, K, JOHNSON, C, GRAY, B, EDWARDS, K, CRAIN, M, BENJAMIN, W. JR

Get full text

Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes by Zheng, Xiaotian, Johnson, Crystal, Lu, Yuanan, Yanagihara, Richard, Hollingshead, Susan, Crain, Marilyn, Benjamin, William, Waites, Ken B.

Get full text